All In Biotech

Drug Trial Radar · NCT00869336

Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)

Phase 2 Study - A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Duration Finding Study Evaluating the Efficacy and Safety of Two Week and Four Week Once Daily Treatment of Luliconazole Cream 1% in Patients With Tinea Pedis

Last checked: Nov 20, 2026Latest source record: Jun 21, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 147 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

147

Actual

Start

Mar 2009

Primary completion

Sep 2009

Study completion Sep 2009

Sponsor

Lead sponsor
Tinea PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 26, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To examine the safety and optimal duration of Luliconazole Cream 1% treatments for 14 days or 28 days to achieve "complete clearance" at 2 weeks post treatment.

Conditions

  • Tinea Pedis

Interventions

  • Luliconazole Cream 1% - 2 wksDrug

    Topical cream applied daily for 2 weeks

  • Placebo Comparator -2 wksDrug

    Placebo cream applied daily for 2 weeks

  • Luliconazole Cream 1% - 4 wksDrug

    Topical cream applied daily for 4 weeks

  • Placebo Comparator - 4 wksDrug

    Placebo cream applied daily for 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects who achieve complete clearance at 2 weeks post treatmentTime frame: Two weeks post treatment

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Fridley, Minnesota

  • Site not named

    Portland, Oregon

  • Site not named

    Austin, Texas

  • Site not named

    College Station, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.